News & Updates

SZC lowers hyperkalemia risk in HF patients on spironolactone
SZC lowers hyperkalemia risk in HF patients on spironolactone
24 Mar 2025 byStephen Padilla

The use of sodium zirconium cyclosilicate (SZC) among patients with heart failure (HF) and reduced ejection fraction (HFrEF) and hyperkalemia has significantly improved the proportion of those with normokalemia while on optimal spironolactone dose, a study has shown.

SZC lowers hyperkalemia risk in HF patients on spironolactone
24 Mar 2025
HF care puts a dent on SG’s healthcare system
HF care puts a dent on SG’s healthcare system
18 Mar 2025 byAudrey Abella

A study evaluating the annual healthcare burden of heart failure with reduced ejection fraction (HFrEF; EF <40 percent) in Singapore shows that hospital-based HF care has a significant financial impact on Singapore’s healthcare system.

HF care puts a dent on SG’s healthcare system
18 Mar 2025